Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food

ClinicalTrials.gov ID: NCT00845871

Public ClinicalTrials.gov record NCT00845871. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single-arm, Open-label Study of the Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food

Study identification

NCT ID
NCT00845871
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
65 participants

Conditions and interventions

Interventions

  • deferasirox: Drug

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2009
Primary completion
Jul 31, 2010
Completion
Jul 31, 2010
Last update posted
Jul 19, 2021

2009 – 2010

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
Children's Hospital and Research Center Oakland California 94609
Stanford University Palo Alto California 94304-1812
Bay Area Cancer Research Group Pleasant Hill California 94523
University of Colorado Denver, Colorado Sickle Cell Treatment and Research Center Aurora Colorado 80045
Yale University School of Medicine New Haven Connecticut 06520
Medical College of Georgia Augusta Georgia 30912
Children's Memorial Chicago Illinois 60614
Tulane University Health Sciences Center New Orleans Louisiana 70118
University of Maryland Greenebaum Cancer Center Baltimore Maryland 21201
Children's Hospital of Boston Boston Massachusetts 02115
Boston Medical Center Boston Massachusetts 02118
Washington University School of Medicine St Louis Missouri 63110
The Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601
Cancer Institute of New Jersey New Brunswick New Jersey 08901
St Joseph Children's Hospital Paterson New Jersey 07503
Schneider Children's Hospital New Hyde Park New York 11040
New York Presbyterian Hospital New York New York 10065
New York Medical College Valhalla New York 10595
Wake Forest University Health Sciences Winston-Salem North Carolina 27157
University of Oklahoma Oklahoma City Oklahoma 73104
Penn State Children's Hospital Hershey Pennsylvania 17033
St Christopher's Hospital for Children Philadelphia Pennsylvania 19134
Texas Children's Cancer Center and Hematology Services Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00845871, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00845871 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →